PRAVASTATIN

Course overview

PRAVASTATIN IS A MEDICATION USED IN THE MANAGEMENT AND TREATMENT OF PRIMARY HYPERCHOLESTEROLEMIA, HYPERLIPIDEMIA, AND MIXED DYSLIPIDEMIA. IT FALLS UNDER THE CLASS OF COMPETITIVE HYDROXYMETHYLGLUTARYL COENZYME-A (HMG CO-A) REDUCTASE INHIBITORS. THIS ACTIVITY REVIEWS THE INDICATIONS, ACTION, AND CONTRAINDICATIONS FOR PRAVASTATIN AS A VALUABLE AGENT IN THE TREATMENT AND MANAGEMENT OF PRIMARY HYPERCHOLESTEROLEMIA, HYPERLIPIDEMIA, AND MIXED DYSLIPIDEMIA. THIS ACTIVITY WILL HIGHLIGHT THE MECHANISM OF ACTION, ADVERSE EFFECTS, AND OTHER VITAL FACTORS SUCH AS DOSING, PHARMACODYNAMICS, PHARMACOKINETICS, MONITORING, RELEVANT INTERACTIONS PERTINENT FOR MEMBERS OF THE INTERPROFESSIONAL TEAM IN THE TREATMENT AND CARE OF PATIENTS WITH HYPERLIPIDEMIA AND RELATED CONDITIONS.